KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Date Action Amount Person Type
Apr 22, 2024 Sell 6 789 Rangwala Reshma Common Stock
Apr 04, 2024 Sell 3 563 Paulson Richard A. Common Stock
Mar 05, 2024 Sell 3 573 Paulson Richard A. Common Stock
Mar 01, 2024 Sell 5 969 Rangwala Reshma Common
Mar 01, 2024 Sell 6 155 Poulton Stuart Common
Mar 01, 2024 Sell 6 162 Mason Michael Common
Mar 01, 2024 Sell 3 576 Mano Michael Common
Mar 01, 2024 Sell 5 109 Cheng Sohanya Roshan Common
Mar 01, 2024 Sell 19 374 Paulson Richard A. Common
Feb 29, 2024 Sell 15 667 Rangwala Reshma Common
Feb 29, 2024 Sell 16 311 Poulton Stuart Common
Feb 29, 2024 Sell 27 687 Mason Michael Common
Feb 29, 2024 Sell 16 973 Mano Michael Common
Feb 29, 2024 Sell 21 840 Cheng Sohanya Roshan Common
Feb 29, 2024 Sell 80 470 Paulson Richard A. Common
Feb 28, 2024 Buy 198 959 Rangwala Reshma Common Stock
Feb 28, 2024 Buy 188 205 Poulton Stuart Common Stock
Feb 28, 2024 Buy 188 205 Mason Michael Common Stock
Feb 28, 2024 Buy 147 000 Mano Michael Common Stock
Feb 28, 2024 Buy 198 959 Cheng Sohanya Roshan Common Stock
Feb 28, 2024 Buy 442 800 Paulson Richard A. Common Stock
Feb 27, 2024 Sell 2 545 Mason Michael Common Stock
Feb 15, 2024 Sell 5 748 Poulton Stuart Common Stock
Feb 15, 2024 Sell 99 Poulton Stuart Common Stock
Feb 06, 2024 Sell 4 205 Mason Michael Common Stock
Feb 06, 2024 Sell 4 012 Paulson Richard A. Common Stock
Jan 24, 2024 Buy 14 167 Cheng Sohanya Roshan Common Stock
Jan 24, 2024 Buy 14 167 Rangwala Reshma Common Stock
Jan 24, 2024 Buy 13 333 Poulton Stuart Common Stock
Jan 24, 2024 Buy 9 167 Mano Michael Common Stock
Jan 24, 2024 Buy 13 333 Mason Michael Common Stock
Jan 24, 2024 Buy 42 000 Paulson Richard A. Common Stock
Jan 04, 2024 Sell 4 114 Paulson Richard A. Common Stock
Dec 04, 2023 Sell 3 622 Paulson Richard A. Common Stock
Nov 06, 2023 Sell 3 606 Paulson Richard A. Common Stock
Oct 04, 2023 Sell 3 589 Paulson Richard A. Common Stock
Sep 12, 2023 Buy 41 140 Bohlin Garen G Common Stock
Sep 05, 2023 Sell 3 558 Paulson Richard A. Common Stock
Sep 05, 2023 Sell 64 Paulson Richard A. Common Stock
Sep 01, 2023 Sell 6 913 Mason Michael Common Stock
Sep 01, 2023 Sell 3 888 Mano Michael Common Stock
Sep 01, 2023 Sell 7 415 Cheng Sohanya Roshan Common Stock
Aug 31, 2023 Buy 68 000 Su Zhen Nonstatutory Stock Option (right to buy)
Aug 31, 2023 Buy 0 Su Zhen
Aug 07, 2023 Sell 3 722 Paulson Richard A. Common Stock
Jul 28, 2023 Sell 2 845 Poulton Stuart Common Stock
Jul 05, 2023 Sell 3 538 Paulson Richard A. Common Stock
Jun 08, 2023 Sell 1 839 Cheng Sohanya Roshan Common Stock
Jun 05, 2023 Sell 3 536 Paulson Richard A. Common Stock
Jun 02, 2023 Sell 631 Mason Michael Common Stock
May 24, 2023 Buy 34 000 Schor Chen Nonstatutory Stock Option (right to buy)
May 24, 2023 Buy 34 000 Pakianathan Deepika Nonstatutory Stock Option (right to buy)
May 24, 2023 Buy 34 000 Oliger Christy J. Nonstatutory Stock Option (right to buy)
May 24, 2023 Buy 34 000 Mirza Mansoor Raza Nonstatutory Stock Option (right to buy)
May 24, 2023 Buy 34 000 Honig Peter Nonstatutory Stock Option (right to buy)
May 24, 2023 Buy 34 000 Bohlin Garen G Nonstatutory Stock Option (right to buy)
May 24, 2023 Buy 34 000 Greene Barry E Nonstatutory Stock Option (right to buy)
May 04, 2023 Sell 3 805 Paulson Richard A. Common Stock
Apr 20, 2023 Sell 115 Rangwala Reshma Common Stock
Apr 20, 2023 Sell 6 655 Rangwala Reshma Common Stock
Apr 04, 2023 Sell 3 497 Paulson Richard A. Common Stock
Mar 06, 2023 Sell 3 506 Paulson Richard A. Common Stock
Mar 01, 2023 Sell 6 357 Mitchener Stephen Common Stock
Mar 01, 2023 Sell 6 878 Mano Michael Common Stock
Mar 01, 2023 Sell 11 239 Cheng Sohanya Roshan Common Stock
Mar 01, 2023 Sell 11 205 Mason Michael Common Stock
Mar 01, 2023 Sell 33 033 Paulson Richard A. Common Stock
Feb 28, 2023 Buy 100 000 Rangwala Reshma Common Stock
Feb 28, 2023 Buy 95 000 Poulton Stuart Common Stock
Feb 28, 2023 Buy 60 000 Mitchener Stephen Common Stock
Feb 28, 2023 Buy 70 000 Mano Michael Common Stock
Feb 28, 2023 Buy 100 000 Cheng Sohanya Roshan Common Stock
Feb 28, 2023 Buy 95 000 Mason Michael Common Stock
Feb 28, 2023 Buy 252 000 Paulson Richard A. Common Stock
Feb 27, 2023 Sell 2 802 Mason Michael Common Stock
Feb 15, 2023 Sell 5 665 Poulton Stuart Common Stock
Feb 15, 2023 Sell 8 Poulton Stuart Common Stock
Feb 15, 2023 Sell 196 Poulton Stuart Common Stock
Feb 06, 2023 Sell 4 141 Mason Michael Common Stock
Feb 06, 2023 Sell 3 950 Paulson Richard A. Common Stock
Jan 04, 2023 Sell 3 922 Paulson Richard A. Common Stock
Dec 05, 2022 Sell 3 490 Paulson Richard A. Common Stock
Nov 04, 2022 Sell 3 493 Paulson Richard A. Common Stock
Oct 04, 2022 Sell 3 488 Paulson Richard A. Common Stock
Sep 08, 2022 Sell 16 Paulson Richard A. Common Stock
Sep 08, 2022 Sell 3 463 Paulson Richard A. Common Stock
Aug 31, 2022 Buy 20 000 Mitchener Stephen Common Stock
Aug 31, 2022 Buy 30 000 Mitchener Stephen Stock Option (right to buy)
Aug 31, 2022 Buy 30 000 Mitchener Stephen Stock Option (right to buy)
Aug 31, 2022 Buy 30 000 Mano Michael Stock Option (right to buy)
Aug 31, 2022 Buy 30 000 Cheng Sohanya Roshan Common Stock
Aug 31, 2022 Buy 30 000 Mason Michael Common Stock
Aug 31, 2022 Buy 45 000 Mason Michael Stock Option (right to buy)
Aug 31, 2022 Buy 45 000 Mason Michael Stock Option (right to buy)
Aug 15, 2022 Buy 0 Poulton Stuart Common Stock
Aug 15, 2022 Buy 65 000 Poulton Stuart Stock Option (right to buy)
Aug 15, 2022 Buy 45 000 Poulton Stuart Stock Option (right to buy)
Aug 11, 2022 Buy 7 576 Greene Barry E Common Stock
Aug 11, 2022 Sell 7 576 Greene Barry E Stock Option (right to buy)
Aug 11, 2022 Sell 7 576 Greene Barry E Stock Option (right to buy)
INSIDER POWER
71.045
Last 100 transactions
Buy: 2 967 011 | Sell: 444 783 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 71.045.

In total, the insiders bought 2 967 011 and sold 444 783 KPTI shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Karyopharm Therapeutics Inc.

Karyopharm Therapeutics. Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1. Its lead compound, include XPOVIO in combination with bortezo... KPTI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT